Article
PAX6, modified by SUMOylation, plays a protective role in corneal endothelial injury
12 Aug 2020
Abstract excerpt
Abstract Treating corneal endothelial diseases tends to be challenging as human corneal endothelial cells (CECs) do not proliferate in vivo. The pathogenesis or mechanisms underlying injured CECs need further studies. The abnormal expression of PAX6, which is an essential transcription factor for corneal homeostasis, exhibits corneal endothelial defects. However, the effects of PAX6 protein involved in corneal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
